Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-01-08
2008-01-08
Seaman, Margaret D. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S118000
Reexamination Certificate
active
10573204
ABSTRACT:
The compounds of Formula (I)in which R1, R2, R3 and R4 have the meanings as given in the description are novel effective iNOS inhibitors.
REFERENCES:
patent: 4045564 (1977-08-01), Berntsson et al.
patent: 7138399 (2006-11-01), Ulrich
patent: 25 04 252 (1975-08-01), None
patent: 0 125 756 (1984-11-01), None
patent: 9725030 (1997-07-01), None
patent: 00/49015 (2000-08-01), None
patent: 03/080607 (2003-10-01), None
patent: 2005/030768 (2005-04-01), None
patent: 2005/030769 (2005-04-01), None
patent: 2005/030770 (2005-04-01), None
patent: 2005/030771 (2005-04-01), None
Hua et al., Journal of Neuroimmunology, “Role of mitogen-activated protein kinases in inducible nitric oxide synthase and TNF expression in human fetal astrocytes”, 2002, vol. 126, pp. 180-189.
Kim et al., Neurosciences Letters, “Water-soluble chitosan inhibits the production of pro-inflammatory cytokine in human astrocytoma cells activated by amyloid B peptide and interleukin-1B”, 2002, vol. 321, pp. 105-109.
D'Agostino, P., et al., “Tetracycline inhibits the nitric oxide synthase activity induced by endotoxin in cultured murine macrophages”,European Journal of Pharmacology, vol. 346, pp. 283-290, (1998).
Kiss, J., et al., “Time-dependent actions of nitric oxide synthase inhibition on colonic inflammation induced by trinitrobenzene sulphonic acid in rats”,European Journal of Pharmacology, vol. 336, pp. 219-224, (1997).
Sautebin, L., “Prostaglandins and nitric oxide as molecular targets for anti-inflammatory therapy”,Fitoterapia, vol. 71, pp. S48-S57, (2000).
Ohtsuka, M., et al., “PPA250 [3-(2,4-Difluorophenyl)-6-{2-[4-(1H-imidazol-1-ylmethyl) Phenoxy]ethoxy}-2-phenylpyridine], a Novel Orally Effective Inhibitor of the Dimerization of Inducible Nitric-Oxide Synthase, Exhibits an Anti-Inflammatory Effect in Animal Models of Chronic Arthritis”,The Journal of Pharmacology and Experimental Therapeutics, vol. 303, No. 1, pp. 52-57, (2002).
Hansel, T. T., et al., “A selective inhibitor of inducible nitric oxide synthase inhibits exhaled breath nitric oxide in healthy volunteers and asthmatics”,FASEB J, vol. 17, pp. 1298-1300, (2003).
Tinker, A. C., et al., “1,2-Dihydro-4-quinazolinamines: Potent, Highly Selective Inhibitors of Inducible Nitric Oxide Synthase Which Show Antiinflammatory Activity in Vivo”,J. Med. Chem., vol. 46, pp. 913-916, (2003).
Kankuri, E., et al., “Suppression of Acute Experimental Colitis by a Highly Selective Inducible Nitric-Oxide Synthase Inhibitor,N-[3-(Aminomethyl)benzyl]acetamidine”,The Journal of Pharmacology and Experimental Therapeutics, vol. 298, No. 3, pp. 1128-1132, (2001).
Liu, Z-Q, et al., “Specificity of inducible nitric-oxide synthase inhibitors: prospects for their clinical therapy”,Acta Pharmacol Sin, vol. 20, No. 11, pp. 1052-1056, (1999).
Salvemini, D., et al., “Dual Inhibition of Nitric Oxide and Prostaglandin Production Contributes to the Antiinflammatory Properties of Nitric Oxide Synthase Inhibitors”,J. Clin. Invest., vol. 96, pp. 301-308, (1995).
Cuzzocrea, S., et al., “Beneficial effects of GW274150, a novel, potent and selective inhibitor of INOA activity, in a rodent model of collagen-induced arthritis”,European Journal of Pharmacology, vol. 453, pp. 119-129, (2002).
Altana Pharma AG
Goldberg Joshua B.
McGee Sheldon M.
Rahmani Niloofar
Seaman Margaret D.
LandOfFree
Aminopyridine-derivatives as inductible no-synthase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aminopyridine-derivatives as inductible no-synthase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aminopyridine-derivatives as inductible no-synthase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3917814